Auris Medical Provides Update on Intranasal Betahistine Development Program
03 avr. 2020 17h00 HE
|
Auris Medical AG
Phase 1b trial with AM-201 proceeding as planned to data read-out in early May 2020Enrollment into Phase 2 trial with AM-125 impacted by COVID-19 pandemicCompany to report 2019 second-half and full...
Amarex, an NSF International Company, Executes Five Rush COVID-19 Related Submissions to the FDA
02 avr. 2020 11h22 HE
|
NSF International
Ann Arbor, Mich., USA, April 02, 2020 (GLOBE NEWSWIRE) -- In early March 2020, Amarex Clinical Research LLC, an NSF International company, executed a rush submission of an emergency use...
Amarex, an NSF International Company, Executes Five Rush COVID-19 Related Submissions to the FDA
02 avr. 2020 08h01 HE
|
NSF International
Ann Arbor, April 02, 2020 (GLOBE NEWSWIRE) -- In early March 2020, Amarex Clinical Research LLC, an NSF International company, executed a rush submission of an emergency use Investigational New Drug...
Axiom Real-Time Metrics Mobilizes to Respond to Vital Clinical Trial Needs During COVID-19
30 mars 2020 17h32 HE
|
Axiom Real-Time Metrics Inc
TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is responding to the unique and unprecedented...
PharmaCyte Biotech CEO Discusses Navigating Testing and IND Submission During COVID-19 Pandemic
26 mars 2020 09h00 HE
|
PharmaCyte Biotech
NEW YORK, NY, March 26, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) continues to work with consultants to prepare its Investigational New Drug application (IND). At the same time,...
PRA Health Sciences expands remote clinical study support with its Mobile Health Platform during COVID-19 pandemic
24 mars 2020 16h05 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., March 24, 2020 (GLOBE NEWSWIRE) -- As a response to the ongoing global COVID-19 pandemic, PRA Health Sciences announced today the expansion of its industry-leading Mobile Health...
ELISpot and Fluorospot Assay Market To Reach USD 408.8 Million By 2026 | Reports and Data
24 mars 2020 13h00 HE
|
Reports and Data
New York, March 24, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the ELISpot and Fluorospot Assay Market was valued at USD 123.5 million in 2018 and is expected to...
Vineti Announces New Chief Technology Officer
09 mars 2020 08h00 HE
|
Vineti
SAN FRANCISCO, March 09, 2020 (GLOBE NEWSWIRE) -- Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, today announced the hiring of Phil Calvin as the...
Electronic Clinical Outcome Assessment (eCOA) Market Emerging Technology, Investor Analysis and Worldwide Forecast till 2027- Oracle, Parexel International Corporation, ERT Clinical, Bioclinica, IBM Corporation, eClinical Solutions LLC, Medidata, Omnicomm Systems & Others
05 mars 2020 06h01 HE
|
Data Bridge Market Research
SAN FRANCISCO, March 05, 2020 (GLOBE NEWSWIRE) -- Electronic Clinical Outcome Assessment (eCOA) Market is a method of capturing data electronically in clinical trials. It can substantially increase...
Axiom Real-Time Metrics Exhibiting Fusion eClinical Suite at Outsourcing in Clinical Trials West Coast, San Francisco
02 mars 2020 19h57 HE
|
Axiom Real-Time Metrics Inc
SAN FRANCISCO, March 02, 2020 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics (“Axiom”), premier provider of unified eClinical solutions and services is exhibiting March 3-4th, 2020 at the annual...